Quotes IRLAB Therapeutics AB OTC Markets

Stocks

Market Closed - OTC Markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

02:04am	Irlab receives positive patent notice in the US for IRL1117	FW
10-20	Irlab research behind linepemat published in journal	FW

Stock exchange

OTC Markets IRLAF - $ -.--% 0 $

Markets		Price	Change	Volumes
Nasdaq Stockholm	IRLAB A	1.946SEK	+0.93%	1.42M kr
Deutsche Boerse AG	6IRA	0.1688EUR	-2.88%	0 €
OTC Markets	IRLAF	-USD	-.--%	0 $

markets

Daily volume

Estimated daily volume

Record volume 1

10,000

Record volume 2

Record volume 3

Capital turnover ratio

Float rotation

Market Cap (USD)

29,069,294

Net sales (SEK)

57,462,000

Net sales (USD)

5,772,004

Number of employees

Sales / Employee (SEK)

1,853,613

Sales / Employee (USD)

186,194

Free-Float

83.4%

Free-Float capitalization (USD)

13,847,303

STIM

RSI 9 days

RSI 14 days

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
IRLAB THERAPEUTICS AB	-.--%	-.--%	-	-	29.07M
ELI LILLY AND COMPANY	+0.45%	+3.13%	+54.96%	+125.16%	1,140B
JOHNSON & JOHNSON	+0.94%	+4.93%	+39.86%	+78.72%	641B
ABBVIE INC.	+0.39%	+1.44%	+25.77%	+97.48%	507B
ROCHE HOLDING AG	+1.43%	+4.31%	+46.20%	+67.12%	383B
MERCK & CO., INC.	-3.21%	-2.10%	+60.72%	+33.22%	347B
NOVARTIS AG	-0.41%	+2.64%	+22.48%	+49.82%	293B
ASTRAZENECA PLC	+0.23%	+3.66%	+2.57%	+23.69%	266B
AMGEN INC.	+1.22%	+4.63%	+52.40%	+64.85%	240B
GILEAD SCIENCES, INC.	+1.70%	+3.67%	+31.21%	+102.15%	197B
Average	+0.24%	+2.92%	+37.35%	+71.36%	401.38B
Weighted average by Cap.	+0.44%	+2.98%	+41.37%	+83.80%